Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Peter M.O. Wong

Advertisement

Articles by Peter M.O. Wong

Closing the Gaps in Drug Chain of Custody

ByPeter M.O. Wong
April 28th 2016

Pharmaceutical Executive

Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.

Advertisement

Latest Updated Articles

  • Closing the Gaps in Drug Chain of Custody
    Closing the Gaps in Drug Chain of Custody

    April 28th 2016



Advertisement
Advertisement

Trending on PharmExec

1

Sanofi Eyes Insmed in Potential $43B Deal as Dupixent Patent Clock Ticks

2

FDA Approves Livsayis, Regeneron's First siRNA Therapy for Myasthenia Gravis

3

Johnson & Johnson's Strategic Shift: Why Diversification Is Giving Way to Focus

4

Innogen Licenses GLP-1 Therapy Efsubaglutide Alfa to Arcera

5

DISCO, AbbVie Sign AND-Gated Bispecific Deal Worth Up to $2.5B

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us